Publications
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Schilling, W., Jittamala, P., Watson, J., Boyd, S., Luvira, V., Siripoon, T., Ngamprasertchai, T., Batty, E., Cruz, C., Callery, J., Singh, S., Saroj, M., Kruabkontho, V., Ngernseng, T., Tanglakmankhong, N., Tubprasert, J., Abdad, M., Madmanee, W., Kouhathong, J., … White, N. (2023). Lancet Infectious Diseases, 24(1), 36-45.
Characteristics and in-hospital mortality of patients with COVID-19 from the first to fifth waves of the pandemic in 2020 and 2021 in the Japanese Medical Data Vision database
Suzuki, T., Taniguchi, Y., Komiyama, J., Kuno, T., Adomi, M., Abe, T., Inokuchi, R., Miyawaki, A., Imai, S., Saito, M., Ohbe, H., Aso, S., Kamio, T., Tamiya, N., & Iwagami, M. (2023). Heliyon, 9(9).
Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV)
Jittamala, P., Schilling, W., Watson, J., Luvira, V., Siripoon, T., Ngamprasertchai, T., Almeida, P., Ekkapongpisit, M., Cruz, C., Callery, J., Boyd, S., Anunsittichai, O., Hongsuwan, M., Singhaboot, Y., Pagornrat, W., Tuntipaiboontana, R., Kruabkontho, V., Ngernseng, T., Tubprasert, J., … White, N. (2023). The Journal of Infectious Diseases, 228(10), 1318-1325.
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
Yamamoto, S., Yamayoshi, S., Ito, M., Sakai-Tagawa, Y., Nakachi, I., Baba, R., Kamimoto, S., Ogura, T., Hagiwara, S., Kato, H., Nakajima, H., Uwamino, Y., Yagi, K., Sugaya, N., Nagai, H., Saito, M., Adachi, E., Koga, M., Tsutsumi, T., … Kawaoka, Y. (2023). IScience, 26(7).
Outbreaks of COVID-19 in a tuberculosis treatment sanatorium on the Thailand-Myanmar border: a retrospective cohort analysis
Aung, H., Swe, L., Saito, M., Lesseps, S., Janurian, N., Tun, W., Maung Maung, B., Than, A., Watthanaworawit, W., Kaewphanderm, N., Gornsawun, G., Pyae Phyo, A., & Nosten, F. (2023). Wellcome Open Research, 8.
Safety And Efficacy Evaluation Of The Oxyjet Cpap Device Compared To High-flow Nasal Oxygen For Treating Hypoxemic Covid-19 Patients In General Hospital Wards: A Randomized Controlled Trial
Noor, N., Islam, K., Chowdhury, F., Sharif, M., Ratul, R., Jahan, S., Ahmed, K., Ahmed, K., Rashid, M., Muhib, F., Amin, R., Miah, T., & Hasan, T. (2023). Bangladesh Journal of Medicine, 206-207.
A multicenter randomized controlled trial to evaluate the efficacy and safety of nelfinavir in patients with mild COVID-19
Miyazaki, T., Hosogaya, N., Fukushige, Y., Takemori, S., Morimoto, S., Yamamoto, H., Hori, M., Ozawa, Y., Shiko, Y., Inaba, Y., Kurokawa, T., Hanaoka, H., Iwanami, S., Kim, K., Iwami, S., Watashi, K., Miyazawa, K., Umeyama, T., Yamagoe, S., … Kohno, S. (2023). Microbiology Spectrum, 11(3).
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
Uraki, R., Ito, M., Kiso, M., Yamayoshi, S., Iwatsuki-Horimoto, K., Sakai-Tagawa, Y., Furusawa, Y., Imai, M., Koga, M., Yamamoto, S., Adachi, E., Saito, M., Tsutsumi, T., Otani, A., Kashima, Y., Kikuchi, T., Yotsuyanagi, H., Suzuki, Y., & Kawaoka, Y. (2023). The Lancet Infectious Diseases, 23(5), 525-526.
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID
Scott, N., Pearmain, L., Knight, S., Brand, O., Morgan, D., Jagger, C., Harbach, S., Khan, S., Shuwa, H., Franklin, M., Kästele, V., Williams, T., Prise, I., McClure, F., Hackney, P., Smith, L., Menon, M., Konkel, J., Lawless, C., … Mann, E. (2023). European Respiratory Journal, 61(5), 2202226.
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
Uraki, R., Ito, M., Kiso, M., Yamayoshi, S., Iwatsuki-Horimoto, K., Furusawa, Y., Sakai-Tagawa, Y., Imai, M., Koga, M., Yamamoto, S., Adachi, E., Saito, M., Tsutsumi, T., Otani, A., Kikuchi, T., Yotsuyanagi, H., Halfmann, P., Pekosz, A., & Kawaoka, Y. (2023). The Lancet Infectious Diseases, 23(4), 402-403.
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling, W., Jittamala, P., Watson, J., Ekkapongpisit, M., Siripoon, T., Ngamprasertchai, T., Luvira, V., Pongwilai, S., Cruz, C., Callery, J., Boyd, S., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Abdad, M., Piaraksa, N., Suwannasin, K., Hanboonkunupakarn, P., Hanboonkunupakarn, B., … White, N. (2023). ELife, 12.
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia
Ikeda, M., Okugawa, S., Kashiwabara, K., Moritoyo, T., Kanno, Y., Jubishi, D., Hashimoto, H., Okamoto, K., Tsushima, K., Uchida, Y., Mitsumura, T., Igari, H., Tsutsumi, T., Araoka, H., Yatera, K., Yamamoto, Y., Nakamura, Y., Otani, A., Yamashita, M., … Moriya, K. (2023). International Journal of Infectious Diseases, 128, 355-363.
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open- label, randomised, controlled adaptive platform trial
Luvira, V., Schilling, W., Jittamala, P., Watson, J., Boyd, S., Siripoon, T., Ngamprasertchai, T., Almeida, P., Ekkapongpisit, M., Cruz, C., Callery, J., Singh, S., Tuntipaiboontana, R., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Abdad, M., Keayarsa, S., Madmanee, W., … White, N. (2023). In Research Square.
Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta- analysis (vol 2, e000561, 2022)
Guerin, P., McLean, A., Rashan, S., Lawal, A., Watson, J., & Strub-Wourgaft, N. (2023). PLOS GLOBAL PUBLIC HEALTH, 3(4).
Outbreaks of COVID-19 in a tuberculosis treatment sanatorium on the Thailand-Myanmar border: a retrospective cohort analysis.
Aung, H., Swe, L., Saito, M., Lesseps, S., Janurian, N., Tun, W., Maung Maung, B., Than, A., Watthanaworawit, W., Kaewphanderm, N., Gornsawun, G., Pyae Phyo, A., & Nosten, F. (2023). Wellcome Open Research, 8, 272.
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
Takashita, E., Yamayoshi, S., Halfmann, P., Wilson, N., Ries, H., Richardson, A., Bobholz, M., Vuyk, W., Maddox, R., Baker, D., Friedrich, T., O’Connor, D., Uraki, R., Ito, M., Sakai-Tagawa, Y., Adachi, E., Saito, M., Koga, M., Tsutsumi, T., … Kawaoka, Y. (2022). New England Journal of Medicine, 387(22), 2094-2097.
Casirivimab/Imdevimab for Active COVID-19 Pneumonia Which Persisted for Nine Months in a Patient with Follicular Lymphoma during Anti-CD20 Therapy
Nagai, H., Saito, M., Adachi, E., Sakai-Tagawa, Y., Yamayoshi, S., Kiso, M., Kawamata, T., Koga, M., Kawaoka, Y., Tsutsumi, T., & Yotsuyanagi, H. (2022). Japanese Journal of Infectious Diseases, 75(6), 608-611.
Favorable Outcome Following Sotrovimab Monoclonal Antibody in a Patient with Prolonged SARS-CoV-2 Omicron Infection with HIV/AIDS
Adachi, E., Saito, M., Koga, M., Tsutsumi, T., & Yotsuyanagi, H. (2022). Internal Medicine, 61(22), 3459-3462.
HESITANCY IN COVID-19 VACCINE UPTAKE IN UGANDA: Understanding Community Perceptions in Kampala, Mukono and Wakiso Districts
Kibira, D., Mulumba, M., Nanyonga, S., Baguma, C., Hasunira, R., Nsereko, I., Muhumuza, N., Musoke, J., Ssekamwa, F., & Kakinda, M. (2022). Afya na Haki.
Antibody Response to ChAdOx1-nCoV-19 Vaccine Among Recipients in Bangladesh: A Prospective Observational Study
Hoque, A., Barshan, A., Chowdhury, F., Fardous, J., Hasan, M., Khan, A., & Kabir, A. (2021). Infection and Drug Resistance, 14, 5491-5500.
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
Axfors, C., Janiaud, P., Schmitt, A., van’t Hooft, J., Smith, E., Haber, N., Abayomi, A., Abduljalil, M., Abdulrahman, A., Acosta-Ampudia, Y., Aguilar-Guisado, M., Al-Beidh, F., Alejandria, M., Alfonso, R., Ali, M., AlQahtani, M., AlZamrooni, A., Anaya, J.-M., Ang, M., … Danielle, F. (2021). BMC Infectious Diseases, 21.
Conventional oxygen therapy versus CPAP as a ceiling of care in ward-based patients with COVID-19: a multi-centre cohort evaluation.
Bradley, P., Wilson, J., Taylor, R., Nixon, J., Redfern, J., Whittemore, P., Gaddah, M., Kavuri, K., Haley, A., Denny, P., Withers, C., Robey, R., Logue, C., Dahanayake, N., Min, D., Coles, J., Deshmukh, M., Ritchie, S., Malik, M., … Pearmain, L. (2021). EClinicalMedicine, 40, 101122.
Accessibility, inclusivity, and implementation of COVID-19 clinical management guidelines early in the pandemic: a global survey
Pilbeam, C., Malden, D., Newell, K., Dagens, A., Kennon, K., Michelen, M., Gobat, N., & Sigfrid, L. (2021). Wellcome Open Research, 6.
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions
Schilling, W., Callery, J., Chandna, A., Hamers, R., Watson, J., & White, N. (2021). Wellcome Open Research, 6, 71-71.
A Middle-Aged Man Presented with Quadriparesis during COVID-19 Pandemic
Chowdhury, F., Paul, S., Aman, S., Haque, A., Rafiquzzaman, M., Rahman, M., & Chowdhury, F. (2021). Case Reports in Neurology, 13(2), 529-534.